Stocks Hitting 52-Week Highs
October 06, 2014 at 10:15 AM EDT
Durata Therapeutics (NASDAQ: DRTX) shares reached a new 52-week high of $23.66 after Actavis (NYSE: ACT) announced its plans to buy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.